Medtronic PLC MDT
88.64
0.13
0.15%
as of 25 Sep
- Market cap
- $112.2B
- P/E
- 21.7×
Follow MDT
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years
Medtronic PLC (MDT) P/B ratio
As of 25 September 2026, Medtronic PLC (MDT) trades at a P/B ratio of 2.2×. Over the past ten years it has ranged from 1.5× (July 2015) to 3.9× (January 2015); the current reading is higher than 37% of that period. That is below the Medical Devices industry median of 2.5× and below the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2026 | 2.1× | (8.21%) |
| FY2025 | 2.3× | 6.87% |
| FY2024 | 2.1× | (9.47%) |
| FY2023 | 2.3× | (11.12%) |
| FY2022 | 2.6× | (23.04%) |
| FY2021 | 3.4× | 32.62% |
| FY2020 | 2.6× | 8.05% |
| FY2019 | 2.4× | 11.33% |
| FY2018 | 2.1× | (6.76%) |
| FY2017 | 2.3× | 6.79% |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jul 2026 | 2.1× | 3.68% |
| Apr 2026 | 2.1× | (22.59%) |
| Jan 2026 | 2.7× | 12.51% |
| Oct 2025 | 2.4× | (0.95%) |
| 43 more quarters | Free account |
Against its own ten years
Low 1.5×
High 3.9×
Ten-year median
2.3×
Current reading's percentile
37
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| PHG Koninklijke Philips N.V. compare | 1.8× |
| MDT Medtronic PLC | 2.2× |
| BSX Boston Scientific Corporation compare | 2.6× |
| GEHC GE HealthCare Technologies Inc. compare | 2.7× |
| STE STERIS plc compare | 2.8× |
| ABT Abbott Laboratories compare | 3.4× |
| SYK Stryker Corporation compare | 4.4× |
| EW Edwards Lifesciences Corporation compare | 4.6× |
| DXCM DexCom, Inc. compare | 12.6× |
| Medical Devices industry median | 2.5× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on MDT
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement